St. Jude Cloud lets researchers view over 5,000 whole-genome, 5,000 whole-exome and 1,200 RNA-Seq datasets from more than 5,000 pediatric cancer patients and survivors.
No tool has been able to simultaneously analyze genomic sequencing data for copy number variations, or aneuploidy, in which chromosomes get duplicated and structural rearrangements, such as DNA insertions, deletions, duplications or rearrangements. Until now.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Dell Healthcare & Life Sciences announced Monday morning that it has hired Dr. Nick van Terheyden as its new CMO. Van Terheyden comes over from Nuance Communications, where he served as CMIO for five years.
Google’s push into the genome storage and research market seems like a natural move to make personalized medicine a mainstream treatment option. And the price for storing genomic data has plummeted to a consumer friendly $25 per month. But comments in response to a recent article from MIT Technology Review illustrate the mixed feelings we […]
Phoenix Children’s Hospital, with the help of a billionaire physician, is launching the Chan Soon-Shiong Children’s Precision Medicine Institute, which will include a cloud-based super computer that lets physicians utilize genome data that could help lead to more personalized treatments. The project is being backed by billionaire and pharmaceutical entrepreneur Dr. Patrick Soon-Shiong. It will […]
Data access, quantity, and quality drive innovation in clinical research, both for studies across whole populations and for personalized medicine that focuses on an individual’s disease, diagnosis, and response to treatment. New technologies such as Next Generation Sequencing (NGS) for whole genomes and high-resolution slide imaging are creating terabytes of data that were considered too […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
He’s only 15, but Intel International Science and Engineering Fair winner Nathan Han may be on his way to making some important advances in cancer research. His winning invention is a machine-learning software tool he’s been using to examine in detail the characteristics of several mutations of the BRCA1 gene, which produces tumor suppressor proteins. […]
“Your [genomic] sequence changed everything we know about your diseases,” a clinician told Eric Dishman, general manager of Intel’s Health & Life Sciences Group, about two years ago. “We mistreated you for more than two decades.” His doctors changed his regimen based on this new information. Within three months, Dishman was cancer-free and, as a […]
Thanks to technology and the changing culture of medicine, those of us who don’t have thousands of dollars to donate to medical research have easier ways to contribute. Instead of money, we can donate our knowledge and our data. Crowdsourcing has tremendous potential in speeding up and broadening the scope of medical research, and the […]
In a demonstration of the booming field of genomic research, investors have pumped $21.3 million into a company that makes and manufactures genome-wide research tools and services. OriGene Technologies said its Series C was led by Chinese venture firm Qiming Venture Partners and Kleiner Perkins Caufield Byers China, with participation from previous investor IDG-Accel, a […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Eleven scientists found out today that they are the “inaugural laureates” of the BreakThrough Prize in Life Sciences. Each one will receive $3 million from a new foundation of the same name. Seven of the winners are working on some aspect of cancer research from telomeres to cancer metabolism to tumor suppressor genes. In an […]
President Barack Obama defended research funding against the potential cuts from the sequester. It was gratifying to see a clear illustration of the value of government research and government funding for research.
With $10 million in new investments and a $4.5 million grant from National Human Genome Research Institute, a Cambridge DNA sequencing company is preparing to launch its version of a desktop DNA sequencer next year. “To carry out the process (of DNA sequencing), you need a team that understands how to do microbiology, informatics, and […]
Angelman syndrome has no cure and few treatments but the rare genetic disorder now has the first clinic in the nation dedicated to the condition. The University of North Carolina at Chapel Hill has opened its Comprehensive Angelman Syndrome Clinic to offer counseling, support and services to patients who have Angelman syndrome. The clinic, a […]
North Carolina biotechnology company Precision BioSciences has secured a patent victory for its genome engineering technology. The U.S. Patent and Trademark Office has rejected claims from French company Cellectis that alleges that Precision is infringing on a Cellectis patent. The USPTO decision rejects Cellectis’ claims as being anticipated by or obvious in the context of […]